EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Autoreactive IgE: Pathogenic role and therapeutic target in autoimmune diseases

Nicolas Charles iD, Inge Kortekaas-Krohn iD, Emek Kocaturk iD, Jörg Scheffel iD, Sabine Altrichter iD, Carolin Steinert iD, Yi-Kui Xiang iD, Jan Gutermuth iD, Laurent L Reber iD, Marcus Maurer iD

Allergy · 2023-12 · 78 (12) · 3118-3135

DOI: 10.1111/all.15843 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Allergy, online erschienen am 09.08.2023. Verfasst von Nicolas Charles und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculté de Médecine site Bichat, Centre de Recherche sur l'Inflammation, INSERM UMR1149, CNRS EMR8252, Université Paris Cité, Paris, France. Hauptthemen laut MEDLINE: Immunoglobulin E, Autoimmune Diseases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 184 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Research Council, Agence Nationale de la Recherche, Centre National de la Recherche Scientifique.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmunity is the break of tolerance to self‐antigens that leads to organ‐specific or systemic diseases often characterized by the presence of pathogenic autoreactive antibodies (AAb) produced by plasmablast and/or plasma cells. AAb are prevalent in the general population and not systematically associated with clinical symptoms. In contrast, in some individuals, these AAb are pathogenic and drive the development of signs and symptoms of antibody‐mediated autoimmune diseases (AbAID). AAb production, isotype profiles, and glycosylations are promoted by pro‐inflammatory triggers linked to genetic, environmental, and hormonal parameters. Recent evidence supports a role for pathogenic AAb of the IgE isotype in a number of AbAID. Autoreactive IgE can drive the activation of mast cells, basophils, and other types of FcεRI‐bearing cells and may play a role in promoting autoantibody production and other pro‐inflammatory pathways. In this review, we discuss the current knowledge on the pathogenicity of autoreactive IgE in AbAID and their status as therapeutic targets. We also highlight unresolved issues including the need for assays that reproducibly quantify IgE AAbs, to validate their diagnostic and prognostic value, and to further study their pathophysiological contributions to AbAID.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin EAutoimmune DiseasesHumansBasophilsOmalizumabAutoimmunityReceptors, IgE

Stichwörter der Autor:innen

UB-221antibody-mediated autoimmune diseasesautoallergyautoreactive IgEligelizumabomalizumab

Substanzen

Immunoglobulin EOmalizumabReceptors, IgE

Autor:innen und Institutionen

  • Faculté de Médecine site Bichat, Centre de Recherche sur l'Inflammation, INSERM UMR1149, CNRS EMR8252, Université Paris Cité, Paris, France.
  • Laboratoire d'Excellence Inflamex, Université Paris Cité, Paris, France.
  • Vrije Universiteit Brussel (VUB), Skin Immunology & Immune Tolerance (SKIN) Research Group, Brussels, Belgium.
  • Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
  • Department of Dermatology, Koç University School of Medicine, Istanbul, Turkey.
  • Institute of Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

ORCID-Profile: Nicolas Charles, Inge Kortekaas-Krohn, Emek Kocaturk, Jörg Scheffel, Sabine Altrichter, Carolin Steinert, Yi-Kui Xiang, Jan Gutermuth, Laurent L Reber, Marcus Maurer

Förderung

  • European Research Council
  • Agence Nationale de la Recherche
  • Centre National de la Recherche Scientifique
  • Fondation pour la Recherche Médicale
  • Fonds Wetenschappelijk Onderzoek
  • Institut National de la Santé et de la Recherche Médicale

Zitieren

APA

Charles, N., Kortekaas-Krohn, I., Kocaturk, E., Scheffel, J., Altrichter, S., Steinert, C., Xiang, Y. K., Gutermuth, J., Reber, L. L., & Maurer, M. (2023). Autoreactive IgE: Pathogenic role and therapeutic target in autoimmune diseases. Allergy, 78(12), 3118-3135. https://doi.org/10.1111/all.15843

Vancouver

Charles N, Kortekaas-Krohn I, Kocaturk E, Scheffel J, Altrichter S, Steinert C, et al. Autoreactive IgE: Pathogenic role and therapeutic target in autoimmune diseases. Allergy. 2023;78(12):3118-3135. doi:10.1111/all.15843

BibTeX
@article{Charles2023,
  author = {Charles, Nicolas and Kortekaas-Krohn, Inge and Kocaturk, Emek and Scheffel, Jörg and Altrichter, Sabine and Steinert, Carolin and Xiang, Yi-Kui and Gutermuth, Jan and Reber, Laurent L and Maurer, Marcus},
  title = {Autoreactive IgE: Pathogenic role and therapeutic target in autoimmune diseases},
  journal = {Allergy},
  year = {2023},
  volume = {78},
  number = {12},
  pages = {3118--3135},
  doi = {10.1111/all.15843}
}
Kostenlos starten →